Xconomy Health Tech

Business, Life Sciences, and Technology News

Tapping Into the Innovation Grid: J&J, Data, and a Shifting Healthcare Focus

Johnson & Johnson’s global head of external innovation says there needs to be a shift in how healthcare research is funded to focus on early detection and curing rather than managing diseases.

“When you look at the investment in research in the pharma industry, it’s all designed to treat established diseases,” William Hait, global head of Johnson & Johnson (NYSE: JNJ) External Innovation, told delegates at the BIO-Europe Spring event, held digitally last week due to the coronavirus crisis.

While there have been notable exceptions—particularly in the cardiovascular diseases where Hait said it was realized early on that decreasing... Read more »

Tue, 03/31/2020 - 04:00